{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T21:42:48Z","timestamp":1748295768451},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,3,1]]},"DOI":"10.2169\/internalmedicine.9666-22","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T22:12:10Z","timestamp":1660083130000},"page":"797-802","source":"Crossref","is-referenced-by-count":2,"title":["Inflammatory Myopathy Associated with Anti-mitochondrial Antibody-negative Primary Biliary Cholangitis Diagnosed by a Liver Biopsy"],"prefix":"10.2169","volume":"62","author":[{"given":"Mitsuhiro","family":"Kainaga","sequence":"first","affiliation":[{"name":"Department of Neurology, Yokohama Rosai Hospital, Japan"},{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Kakuta","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Research, National Center of Neurology and Psychiatry, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Imafuku","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yokohama Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Maeda MH, Tsuji S, Shimizu J. Inflammatory myopathies associated with anti-mitochondrial antibodies. Brain 135: 1767-1777, 2012.","DOI":"10.1093\/brain\/aws106"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. European Association for the Study of the Liver. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol 67: 145-172, 2017.","DOI":"10.1016\/j.jhep.2017.03.022"},{"key":"3","unstructured":"3. Uhl GS, Baldwin JL, Arnett FC. Primary biliary cirrhosis in systemic sclerosis (scleroderma) and polymyositis. Johns Hopkins Med J 135: 191-198, 1974."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Uenaka T, Kowa H, Ohtsuka Y, et al. Less limb muscle involvement in myositis patients with anti-mitochondrial antibodies. Eur Neurol 78: 290-295, 2017.","DOI":"10.1159\/000481503"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Mauhin W, Mariampillai K, Allenbach Y, Charuel JL, Musset L, Benveniste O. Anti-mitochondrial antibodies are not a hallmark of severity in idiopathic inflammatory myopathies. Joint Bone Spine 85: 375-376, 2018.","DOI":"10.1016\/j.jbspin.2017.04.004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Albayda J, Khan A, Casciola-Rosen L, Corse AM, Paik JJ, Christopher-Stine L. Inflammatory myopathy associated with anti-mitochondrial antibodies: a distinct phenotype with cardiac involvement. Semin Arthritis Rheum 47: 552-556, 2018.","DOI":"10.1016\/j.semarthrit.2017.06.004"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hou Y, Liu M, Luo YB, et al. Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: clinical features and treatment outcomes in a Chinese cohort. Neuromuscul Disord 29: 5-13, 2019.","DOI":"10.1016\/j.nmd.2018.11.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Matsumoto K, Tanaka H, Yamana S, et al. Successful steroid therapy for heart failure due to myocarditis associated with primary biliary cirrhosis. Can J Cardiol 28: 515.e3-e6, 2012.","DOI":"10.1016\/j.cjca.2011.12.010"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Varga J, Heiman-Patterson T, Mu\u00f1oz S, Love LA. Myopathy with mitochondrial alterations in patients with primary biliary cirrhosis and antimitochondrial antibodies. Arthritis Rheum 36: 1468-1475, 1993.","DOI":"10.1002\/art.1780361020"},{"key":"10","unstructured":"10. Matsui K, Aizawa Y, Inoue K, Yaguchi H, Toda G. Polymyositis with marked paravertebral muscle atrophy in patients with primary biliary cirrhosis. Rinsho Shinkeigaku (Clin Neurol) 40: 694-700, 2000 (in Japanese)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Can\u00e7ado GGL, Braga MH, Ferraz MLG, et al. Anti-mitochondrial antibody-negative primary biliary cholangitis is part of the same spectrum of classical primary biliary cholangitis. Dig Dis Sci 67: 3305-3312, 2021.","DOI":"10.1007\/s10620-021-07122-y"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Chatzipantelis P, Giatromanolaki A. Early histopathologic changes in primary biliary cholangitis: does &apos;minimal change&apos; primary biliary cholangitis exist? A pathologist&apos;s view. Eur J Gastroenterol Hepatol 33: e7-e12, 2021.","DOI":"10.1097\/MEG.0000000000001876"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Dahlqvist G, Gaouar F, Carrat F, et al. Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis. Hepatology 65: 152-163, 2017.","DOI":"10.1002\/hep.28859"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hirschfield GM, Heathcote EJ. Antimitochondrial antibody-negative primary biliary cirrhosis. Clin Liver Dis 12: 323-ix, 2008.","DOI":"10.1016\/j.cld.2008.02.003"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/5\/62_9666-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:31:40Z","timestamp":1715315500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/5\/62_9666-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9666-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"article-number":"9666-22"}}